Nicole L. Grimm

Ms. Grimm’s recent transactional experience includes counseling on the $17.3 billion acquisition of a major health insurer, the $6.1 billion acquisition of a major medical device manufacturer, the $5.8 billion restructuring of a major pharmaceutical manufacturer, the $3 billion divestiture of a major consumer products manufacturer, the $2.2 billion acquisition of a leading behavioral health provider, the acquisition of a national pharmacy chain, the initial public offerings of pharmaceutical and medical device manufacturers, and the acquisitions and divestitures of health care and life sciences data analysis and management companies. Ms. Grimm advises clients on all aspects of health care and life sciences deals, including transaction structures, due diligence, and regulatory and licensing compliance.

She also advises on government enforcement and corporate investigation matters and complex civil litigation, including qui tam matters, securities litigation, and class actions. Her recent compliance and enforcement experience includes conducting an internal corporate investigation into alleged clinical trial fraud and managing a decade-long qui tam investigation involving multiple federal and state agencies.

Ms. Grimm is active in pro bono activities and has been named as a winner of the Klepper Prize for Volunteer Excellence from the Legal Aid Society of the District of Columbia for her work on behalf of domestic violence survivors. She also currently serves in a leadership role with the Impact Project in Skadden’s Washington, D.C. office.